4S30 A 1,16,5.1,0.0414,0.8,18.8,Erk2 Intrinsically Active Mutant (i84a)
2EIB A 2,19,4.9,0.0191,0.9,10.5,Crystal Structure Of Galactose Oxidase, W290h Mutant
4A0B C 3,22,6.0,0.0026,1.0,4.5,Structure Of Hsddb1-Drddb2 Bound To A 16 Bp Cpd-Duplex ( Pyrimidine At D-1 Position) At 3.8 A Resolution (Cpd 4)ÿ
4XEY B 2,22,5.2,0.0265,1.0,0.0,Crystal Structure Of An Sh2-kinase Domain Construct Of C-abl Tyrosine Kinase
2YM5 A 1,26,5.2,0.0275,1.0,7.7,Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex With Inhibitorsÿ
4XEY A 1,22,5.1,0.0400,1.0,0.0,Crystal Structure Of An Sh2-kinase Domain Construct Of C-abl Tyrosine Kinase
4IHR A ,30,6.7,0.0080,1.0,0.0,Crystal Structure Of Recombinant Kirola (act D 11)
3JBY D 2,22,4.7,0.0444,1.0,4.5,Cryo-electron Microscopy Structure Of Rag Paired Complex (c2 Symmetry)
3V5L B 1,18,5.2,0.0220,1.0,0.0,Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 542
2WMU A 1,26,5.1,0.0324,1.0,7.7,Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex With Inhibitorsÿ
2W9P B ,29,6.6,0.0023,1.0,6.9,Crystal Structure Of Potato Multicystatinÿ
3IO7 A 1,22,5.1,0.0336,1.0,4.5,2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2ÿ
4C62 B 1,23,5.1,0.0385,1.0,4.3,Inhibitors Of Jak2 Kinase Domain
1P2A A 1,21,5.1,0.0306,1.0,9.5,The Structure Of Cyclin Dependent Kinase 2 (Ckd2) With A Trisubstituted Naphthostyril Inhibitor
4FSZ A 1,26,5.2,0.0152,1.0,7.7,Crystal Structure Of The Chk1
3UDB F 1,28,5.2,0.0152,1.1,0.0,Crystal Structure Of Snrk2.6ÿ
2WMT A 1,26,5.1,0.0372,1.1,7.7,Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex With Inhibitorsÿ
4IGX A ,30,6.4,0.0122,1.1,0.0,Crystal Structure Of Kirola (act D 11) - Triclinic Form
3JVR A 1,26,5.2,0.0152,1.1,7.7,Characterization Of The Chk1 Allosteric Inhibitor Binding Siteÿ
4UY4 B 3,22,5.2,0.0152,1.1,4.5,1.86 A Structure Of Human Spindlin-4 Protein In Complex With Histone H3k4me3 Peptide
3JVS A 1,26,5.2,0.0152,1.1,7.7,Characterization Of The Chk1 Allosteric Inhibitor Binding Siteÿ
2XK3 A 1,27,5.3,0.0308,1.1,7.4,Structure Of Nek2 Bound To Cct244744ÿ
3PA5 A 1,28,5.2,0.0152,1.1,7.1,X-Ray Crystal Structure Of Compound 1 Bound To Human Chk1 Kinase Domainÿ
3IOK A 1,23,5.1,0.0350,1.1,4.3,2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2ÿ
4DZO A ,25,5.0,0.0116,1.1,12.0,Structure Of Human Mad1 C-Terminal Domain Reveals Its Involvement In Kinetochore Targetingÿ
4DZO A 1,25,5.0,0.0098,1.1,12.0,Structure Of Human Mad1 C-Terminal Domain Reveals Its Involvement In Kinetochore Targetingÿ
4IGX B ,30,6.2,0.0355,1.1,0.0,Crystal Structure Of Kirola (act D 11) - Triclinic Form
4IGW B ,30,6.1,0.0481,1.1,0.0,Crystal Structure Of Kirola (act D 11) In P6122 Space Group
3UYS B 1,22,5.2,0.0224,1.1,9.1,Crystal Structure Of Apo Human Ck1dÿ
4IH2 A ,30,6.5,0.0091,1.1,0.0,Crystal Structure Of Kirola (act D 11) From Crystal Soaked With 2- Aminopurine
3ZUU A 1,30,5.1,0.0305,1.1,0.0,The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Goldÿ
4XRN D ,30,6.0,0.0316,1.1,3.3,Pilz Domain With C-di-gmp Of A Protein From Pseudomonas Aeruginosa
5DAC B 2,26,5.1,0.0090,1.1,19.2,Atp-gamma-s Bound Rad50 From Chaetomium Thermophilum In Complex With Dna
3SXR A 1,26,5.2,0.0152,1.1,3.8,Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinibÿ
4IGV A ,30,6.5,0.0092,1.1,0.0,Crystal Structure Of Kirola (act D 11)
3OM6 A 3,34,5.8,0.0224,1.1,11.8,Crystal Structure Of B. Megaterium Levansucrase Mutant Y247aÿ
4YTC A 1,23,5.1,0.0318,1.1,4.3,Discovery Of Vx-509 (decernotinib): A Potent And Selective Janus Kinase (jak) 3 Inhibitor For The Treatment Of Autoimmune Disease
4A9S A 1,26,5.2,0.0212,1.1,3.8,Crystal Structure Of Human Chk2 In Complex With Benzimidazole Carboxamide Inhibitor
3JY9 A 1,23,5.1,0.0357,1.1,4.3,Janus Kinase 2 Inhibitorsÿ
3UDB B 1,29,5.4,0.0191,1.1,0.0,Crystal Structure Of Snrk2.6ÿ
2PMI C 1,22,5.1,0.0420,1.1,4.5,Structure Of The Pho85-Pho80 Cdk-Cyclin Complex Of The Phosphate-Responsive Signal Transduction Pathway With Bound Atp-Gamma-S
3ZUT A 1,30,5.1,0.0374,1.1,0.0,The Structure Of Ost1 (D160a) Kinaseÿ
2WTD A 1,24,5.2,0.0272,1.1,4.2,Crystal Structure Of Chk2 In Complex With An Inhibitorÿ
3KCK A 1,23,5.1,0.0320,1.1,4.3,A Novel Chemotype Of Kinase Inhibitorsÿ
4YC8 B 1,24,5.2,0.0152,1.1,0.0,C-helix-out Binding Of Dasatinib Analog To C-abl Kinase
4FSR A 1,26,5.2,0.0152,1.1,7.7,Crystal Structure Of The Chk1
4YTF A 1,23,5.1,0.0354,1.1,4.3,Discovery Of Vx-509 (decernotinib): A Potent And Selective Janus Kinase (jak) 3 Inhibitor For The Treatment Of Autoimmune Diseases
2B54 A 1,22,6.0,0.0244,1.1,9.1,Human Cyclin Dependent Kinase 2 (Ckd2)complexed With Din- 232305ÿ
3OM5 A 3,34,5.7,0.0245,1.2,11.8,Crystal Structure Of B. Megaterium Levansucrase Mutant N252aÿ
3OM4 C 3,34,5.8,0.0491,1.2,11.8,Crystal Structure Of B. Megaterium Levansucrase Mutant K373aÿ
4BDE A 1,25,5.2,0.0267,1.2,4.0,Fragment-based Screening Identifies A New Area For Inhibitor Binding To Checkpoint Kinase 2 (chk2)
4LGG A 1,18,5.1,0.0399,1.2,0.0,Structure Of 3mb-pp1 Bound To Analog-sensitive Src Kinase
2C47 C 1,23,6.7,0.0001,1.2,0.0,Structure Of Casein Kinase 1 Gamma 2ÿ
2C47 D 1,23,5.5,0.0147,1.2,0.0,Structure Of Casein Kinase 1 Gamma 2ÿ
4LG4 B 1,30,5.3,0.0326,1.2,13.3,Structural Basis For Autoactivation Of Human Mst2 Kinase And Its Regulation By Rassf5
3O61 A 1,31,5.0,0.0109,1.2,3.2,Structure Of The E100a E.Coli Gdp-Mannose Hydrolase (Yffh) In Complex With Gdp-Mannose And Mg++ÿ
4HXG F 1,32,6.5,0.0356,1.2,3.1,Pyrococcus Horikoshii Acylaminoacyl Peptidase (orthorhombic Crystal Form)
4EOR A 1,28,5.6,0.0092,1.2,10.7,Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Nu6102
4HXG C 5,32,6.7,10e-4.5,1.2,3.1,Pyrococcus Horikoshii Acylaminoacyl Peptidase (orthorhombic Crystal Form)
2G9X C 1,28,5.7,0.0087,1.2,10.7,Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN Complex With The Inhibitor Nu6271
3NMU F 1,18,5.1,0.0477,1.2,0.0,Crystal Structure Of Substrate-Bound Halfmer Box CD RNPÿ
3KZT B ,32,5.2,0.0209,1.2,0.0,Crystal Structure Of Protein Of Unknown Function (Np_812423.1) From Bacteroides Thetaiotaomicron Vpi-5482 At 2.10 A Resolutionÿ
4RT1 A ,28,6.7,0.0035,1.2,3.6,Structure Of The Alg44 Pilz Domain (r95a Mutant) From Pseudomonas Aeruginosa Pao1 In Complex With C-di-gmp
4CQE B 1,22,5.1,0.0463,1.2,0.0,B-raf Kinase V600e Mutant In Complex With A Diarylthiazole B-raf Inhibitor
4IH0 A ,30,6.2,0.0343,1.3,0.0,Crystal Structure Of Kirola (act D 11) From Crystal Soaked With Serotonin
4XRN C ,31,5.9,0.0439,1.3,3.2,Pilz Domain With C-di-gmp Of A Protein From Pseudomonas Aeruginosa
2B53 A 1,24,6.1,0.0185,1.3,8.3,Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With Din- 234325ÿ
2Y4I C ,30,6.5,0.0105,1.3,10.0,Ksr2-Mek1 Heterodimerÿ
4HXF B 5,32,6.6,10e-4.5,1.3,3.1,Acylaminoacyl Peptidase In Complex With Z-gly-gly-phe-chloromethyl Ketone
4RT1 B ,30,6.5,0.0084,1.3,3.3,Structure Of The Alg44 Pilz Domain (r95a Mutant) From Pseudomonas Aeruginosa Pao1 In Complex With C-di-gmp
3NVK J 1,21,5.1,0.0372,1.3,0.0,Structural Basis For Substrate Placement By An Archaeal Box CD Ribonucleoprotein Particleÿ
3V8W B 1,24,5.1,0.0305,1.3,0.0,Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 469
3EN7 B 1,17,5.2,0.0152,1.3,0.0,Targeted Polypharmacology: Crystal Structure Of The C-Src Kinase Domain In Complex With S1, A Multitargeted Kinase Inhibitor
5CY3 A 1,25,6.0,0.0235,1.3,0.0,Syk Catalytic Domain Complexed With A Potent And Orally Bioavailable Benzisothiazole Inhibitor
3EN6 A 1,17,5.1,0.0373,1.3,0.0,Targeted Polypharmacology: Crystal Structure Of The C-Src Kinase Domain In Complex With Pp102, A Multitargeted Kinase Inhibitor
3UYT D 1,24,6.1,0.0195,1.3,4.2,Crystal Structure Of Ck1d With Pf670462 From P1 Crystal Formÿ
4NCT C 1,28,6.2,0.0255,1.3,10.7,Human Dyrk1a In Complex With Pkc412
2WQB A 1,24,6.2,0.0015,1.3,8.3,Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitorÿ
2CHL A 1,30,5.6,0.0389,1.3,3.3,Structure Of Casein Kinase 1 Gamma 3
3UGF A 3,29,5.3,0.0068,1.3,10.3,Crystal Structure Of A 6-Sst6-Sft From Pachysandra Terminalisÿ
4EOL A 1,29,5.8,0.0051,1.3,10.3,Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Ro3306
4XRN A ,28,6.3,0.0208,1.3,3.6,Pilz Domain With C-di-gmp Of A Protein From Pseudomonas Aeruginosa
3F9N A 1,31,5.2,0.0152,1.3,6.5,Crystal Structure Of Chk1 Kinase In Complex With Inhibitor 38ÿ
1H1P C 1,30,5.7,0.0303,1.3,10.0,Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058
3PJ2 A 1,26,5.2,0.0252,1.3,3.8,Crystal Structure Of Btk Kinase Domain Complexed With 2-[4-(2- Diethylamino-Ethoxy)-Phenylamino]-6-(4-Fluoro-Phenoxy)-8-Methyl-8h- Pyrido[2,3-D]pyrimidin-7-Oneÿ
4EOM A 1,30,5.7,0.0305,1.3,10.0,Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp
2YM3 A 1,30,5.2,0.0238,1.3,6.7,Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex With Inhibitorsÿ
2IA9 C ,27,6.6,0.0002,1.3,11.1,Structural Genomics, The Crystal Structure Of Spovg From Bacillus Subtilis Subsp. Subtilis Str. 168
4WW9 A 1,17,5.1,0.0408,1.3,5.9,Crystal Structure Of Binary Complex Bud32-cgi121 In Complex With Adp
3WZU A 1,30,6.3,0.0086,1.3,3.3,The Structure Of Map2k7 In Complex With 5z-7-oxozeaenol
2IW8 A 1,29,5.6,0.0105,1.3,10.3,Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
4G3D B 1,26,5.8,0.0472,1.3,0.0,Crystal Structure Of Human Nf-Kappab Inducing Kinase (Nik)
1II8 A ,32,5.6,0.0323,1.3,12.5,Crystal Structure Of The P. Furiosus Rad50 Atpase Domain
4BCQ A 1,30,6.1,0.0020,1.3,10.0,Structure Of Cdk2 In Complex With Cyclin A And A 2-Amino-4- Heteroaryl-Pyrimidine Inhibitor
4RZ7 A 6,30,5.2,0.0152,1.4,10.0,Crystal Structure Of Pvx_084705 With Bound Pci32765
4GK2 A 1,27,5.9,0.0437,1.4,3.7,Human Epha3 Kinase Domain In Complex With Ligand 66
4RT1 C ,31,6.5,0.0083,1.4,3.2,Structure Of The Alg44 Pilz Domain (r95a Mutant) From Pseudomonas Aeruginosa Pao1 In Complex With C-di-gmp
3OZ6 A 1,26,5.6,0.0110,1.4,3.8,Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960ÿ
3RNY A 1,18,5.1,0.0491,1.4,0.0,Crystal Structure Of Human Rsk1 C-Terminal Kinase Domainÿ
1MTP A 2,18,5.0,0.0148,1.4,0.0,The X-Ray Crystal Structure Of A Serpin From A Thermophilic Prokaryote
4BDH A 1,29,5.2,0.0261,1.4,3.4,Fragment-based Screening Identifies A New Area For Inhibitor Binding To Checkpoint Kinase 2 (chk2)
4BDB A 1,27,5.2,0.0259,1.4,3.7,Fragment-based Screening Identifies A New Area For Inhibitor Binding To Checkpoint Kinase 2 (chk2)
2C47 C ,24,6.7,0.0177,1.4,4.2,Structure Of Casein Kinase 1 Gamma 2ÿ
2C47 A 1,24,6.1,0.0025,1.4,4.2,Structure Of Casein Kinase 1 Gamma 2ÿ
2C47 B 1,24,6.1,0.0024,1.4,4.2,Structure Of Casein Kinase 1 Gamma 2ÿ
3MY5 A 1,30,5.5,0.0441,1.4,10.0,Cdk2CYCLINA IN COMPLEX WITH DRBÿ
2XK8 A 1,28,5.3,0.0446,1.4,7.1,Structure Of Nek2 Bound To Cct241799ÿ
4BDD A 1,27,5.2,0.0268,1.4,3.7,Fragment-based Screening Identifies A New Area For Inhibitor Binding To Checkpoint Kinase 2 (chk2)
3J4Q D 1,31,6.3,0.0008,1.4,3.2,Pseudo-atomic Model Of The Akap18-pka Complex In A Bent Conformation Derived From Electron Microscopy
3J4Q E 1,31,6.3,0.0008,1.4,3.2,Pseudo-atomic Model Of The Akap18-pka Complex In A Bent Conformation Derived From Electron Microscopy
3J4R D 1,31,6.3,0.0008,1.4,3.2,Pseudo-atomic Model Of The Akap18-pka Complex In A Linear Conformation Derived From Electron Microscopy
3J4R E 1,31,6.3,0.0008,1.4,3.2,Pseudo-atomic Model Of The Akap18-pka Complex In A Linear Conformation Derived From Electron Microscopy
3BHT A 1,31,6.1,0.0018,1.4,9.7,Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX With The Inhibitor Meriolin 3
3AMY A 1,28,5.3,0.0394,1.4,10.7,Crystal Structure Of Human Ck2 Alpha Complexed With Apigeninÿ
3BHT C 1,30,6.2,0.0017,1.4,10.0,Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX With The Inhibitor Meriolin 3
1JST C ,30,6.7,0.0145,1.4,10.0,Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
1JST C 1,30,6.7,0.0002,1.4,10.0,Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
4BCK C 1,30,5.9,0.0048,1.4,10.0,Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor
2XKE A 1,30,5.4,0.0225,1.4,6.7,Structure Of Nek2 Bound To Aminipyrazine Compound 5ÿ
2LA7 A ,24,6.4,0.0495,1.4,8.3,Nmr Structure Of The Protein Yp_557733.1 From Burkholderia Xenovoransÿ
1LQ8 A 2,18,5.0,0.0143,1.4,5.6,Crystal Structure Of Cleaved Protein C Inhibitor
4IB5 B 1,29,5.6,0.0124,1.4,10.3,Structure Of Human Protein Kinase Ck2 Catalytic Subunit In Complex With A Ck2beta-competitive Cyclic Peptide
3MLQ H ,17,5.2,0.0022,1.4,5.9,Crystal Structure Of The Thermus Thermophilus Transcription-Repair Coupling Factor Rna Polymerase Interacting Domain With The Thermus Aquaticus Rna Polymerase Beta1 Domainÿ
5D10 A 1,22,5.1,0.0327,1.4,0.0,Kinase Domain Of Csrc In Complex With Rl236
3FWQ A 1,31,5.7,0.0071,1.4,9.7,Inactive Conformation Of Human Protein Kinase Ck2 Catalytic Subunitÿ
3BHU A 1,30,6.1,0.0020,1.4,10.0,Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX With The Inhibitor Meriolin 5
2G2I B 1,19,5.2,0.0152,1.4,0.0,A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain
2WEV C 1,30,5.6,0.0097,1.4,10.0,Truncation And Optimisation Of Peptide Inhibitors Of Cdk2, Cyclin A Through Structure Guided Designÿ
3BHH C 1,27,5.7,0.0071,1.4,0.0,Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Iib Isoform 1 (Camk2b)
4BCQ C 1,31,5.9,0.0035,1.4,9.7,Structure Of Cdk2 In Complex With Cyclin A And A 2-Amino-4- Heteroaryl-Pyrimidine Inhibitor
3QD2 B 1,30,5.5,0.0148,1.4,6.7,Crsytal Structure Of Mouse Perk Kinase Domainÿ
3ZFX B 1,27,5.1,0.0318,1.4,3.7,Crystal Structure Of Ephb1
4EOL C 1,30,5.6,0.0105,1.4,10.0,Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Ro3306
3DDP A 1,30,5.5,0.0161,1.4,10.0,Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX With The Inhibitor Cr8
5BX0 A 1,28,5.7,0.0084,1.4,10.7,An Automated Microscale Thermophoresis Screening Approach For Fragment-based Lead Discovery
1OGU A 1,29,5.7,0.0085,1.4,10.3,Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With A 2-Arylamino-4-Cyclohexylmethyl-5-Nitroso-6-Aminopyrimidine Inhibitor
4CFU A 1,30,6.2,0.0017,1.4,10.0,Structure-based Design Of C8-substituted O6- Cyclohexylmethoxyguanine Cdk1 And 2 Inhibitors
4M7I A 1,29,5.5,0.0161,1.4,6.9,Crystal Structure Of Gsk6157 Bound To Perk (r587-r1092, Delete A660- T867) At 2.34a Resolution
3UYS D 1,25,5.3,0.0352,1.4,8.0,Crystal Structure Of Apo Human Ck1dÿ
3U6I A 1,29,6.1,0.0022,1.4,6.9,Crystal Structure Of C-Met In Complex With Pyrazolone Inhibitor 58aÿ
3BHV A 1,31,5.4,0.0234,1.4,9.7,Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX With The Inhibitor Variolin B
4KIO B 1,21,5.1,0.0498,1.4,0.0,Kinase Domain Mutant Of Human Itk In Complex With A Covalently-binding Inhibitor
3F02 A 2,18,4.7,0.0447,1.4,0.0,Cleaved Human Neuroserpinÿ
1O6A B ,20,4.7,0.0437,1.4,0.0,Crystal Structure Of The C-Terminal Fragment Of The Putative Flagelar Motor Switch Protein Flin (Tm0680a) From Thermotoga Maritima At 1.85 A Resolution
3ORC A ,23,4.9,0.0256,1.4,4.3,Crystal Structure Of An Engineered Cro Monomer Bound Nonspecifically To Dnaÿ
3I6W G 2,30,5.1,0.0464,1.4,3.3,Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinaseÿ
3I6W E 2,30,5.2,0.0173,1.4,3.3,Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinaseÿ
1UNG A 1,26,5.6,0.0108,1.4,3.8,Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin
4CFV C 1,30,5.6,0.0101,1.4,10.0,Structure-based Design Of C8-substituted O6- Cyclohexylmethoxyguanine Cdk1 And 2 Inhibitors
1H26 C 1,30,5.6,0.0093,1.4,10.0,Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment Peptide From P53
2DCH X 3,26,5.1,0.0347,1.4,3.8,Crystal Structure Of Archaeal Intron-Encoded Homing Endonuclease I-Tsp061i
4CFU C 1,30,5.6,0.0394,1.4,10.0,Structure-based Design Of C8-substituted O6- Cyclohexylmethoxyguanine Cdk1 And 2 Inhibitors
1P5E C 1,30,5.4,0.0254,1.4,10.0,The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
2KVO A ,27,5.8,0.0196,1.5,0.0,Solution Nmr Structure Of Photosystem Ii Reaction Center Psb28 Protein From Synechocystis Sp.(Strain Pcc 6803), Northeast Structural Genomics Consortium Target Sgr171ÿ
4EOI C 1,30,5.8,0.0059,1.5,10.0,Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306
3TNW C ,30,6.6,0.0168,1.5,10.0,Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508ÿ
4CFN C 1,30,5.8,0.0058,1.5,10.0,Structure-based Design Of C8-substituted O6-cyclohexylmethoxyguanine Cdk1 And 2 Inhibitors
4BCP C 1,30,6.3,0.0010,1.5,10.0,Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor
3WIG A ,27,6.5,0.0075,1.5,11.1,Human Mek1 Kinase In Complex With Ch5126766 And Mgamp-pnp
4RT0 B ,28,6.3,0.0193,1.5,3.6,Structure Of The Alg44 Pilz Domain From Pseudomonas Aeruginosa Pao1 In Complex With C-di-gmp
3UYS A 1,23,5.1,0.0382,1.5,4.3,Crystal Structure Of Apo Human Ck1dÿ
2QYU A 4,23,5.0,0.0129,1.5,4.3,Crystal Structure Of Salmonella Effector Protein Sopa
1FXT A ,30,5.1,0.0344,1.5,6.7,Structure Of A Conjugating Enzyme-Ubiquitin Thiolester Complex
1SWG C ,32,6.3,0.0467,1.5,9.4,Circular Permuted Streptavidin E51A46 IN COMPLEX WITH Biotin
2MVF A ,27,5.7,0.0244,1.5,7.4,Structural Insight Into An Essential Assembly Factor Network On The Pre-ribosome
2ZUY A 6,31,5.5,0.0448,1.5,0.0,Crystal Structure Of Exotype Rhamnogalacturonan Lyase Yesxÿ
4CAA A 2,18,5.2,0.0030,1.5,0.0,Cleaved Antichymotrypsin T345r
4O5P B 4,24,5.0,0.0141,1.5,4.2,Crystal Structure Of An Uncharacterized Protein From Pseudomonas Aeruginosa
4XRW A 2,33,5.8,0.0477,1.5,6.1,Crystal Structure Of The Di-domain Aro/cyc Bexl From The Be-7585a Biosynthetic Pathway
4IGY C ,31,6.1,0.0499,1.5,0.0,Crystal Structure Of Kirola (act D 11) - Triclinic Form
3DDQ C 1,30,5.6,0.0110,1.5,10.0,Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX With The Inhibitor Roscovitine
5HX6 A ,27,6.2,0.0325,1.5,3.7,Crystal Structure Of Rip1 Kinase With A Benzo[b][1,4]oxazepin-4-one
3F02 B 2,19,4.7,0.0409,1.5,0.0,Cleaved Human Neuroserpinÿ
4O3U B 2,32,4.9,0.0237,1.5,0.0,Zymogen Hgf-beta/met With Zymogen Activator Peptide Zap2.3
3TNW C 1,30,6.6,0.0002,1.5,10.0,Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508ÿ
3DOG A 1,30,5.5,0.0137,1.5,10.0,Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN Complex With The Inhibitor N-&-N1
2UUE A 1,28,5.7,0.0080,1.5,10.7,Replace: A Strategy For Iterative Design Of Cyclin Binding Groove Inhibitors
2IW9 A 1,30,5.6,0.0109,1.5,10.0,Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor
3EN7 A 1,22,5.2,0.0152,1.5,0.0,Targeted Polypharmacology: Crystal Structure Of The C-Src Kinase Domain In Complex With S1, A Multitargeted Kinase Inhibitor
4CI2 A 3,28,6.7,0.0001,1.5,3.6,Structure Of The Ddb1-crbn E3 Ubiquitin Ligase Bound To Lenalidomide
